REFURBNA-15 TABLETS
REFURBNA-15 TABLETS
Product Details :
| Product Name | REFURBNA-15 TABLETS |
|---|---|
| Category | Anti-fibrotic / Pulmonology |
| Usage/Application | Treatment of IPF, SSc-ILD, and chronic lung fibrosis |
| Dosage Form | Tablet |
| Composition | Nintedanib 150 mg |
| Packaging Size | 10 x 10 Tablets |
Composition: Tolvaptan 15mg Packing: 10x1x4 Alu-Alu Description : REFURBNA-15 Tablets contain Nintedanib 150 mg, a tyrosine kinase inhibitor used to treat idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and other chronic fibrosing interstitial lung diseases with a progressive phenotype. It works by inhibiting multiple pathways involved in fibrosis and inflammation, helping to slow down lung function decline. REFURBNA-15 is typically prescribed as a part of long-term therapy and should be taken under the supervision of a pulmonologist or specialist. It is essential to monitor liver function during treatment.